Concinnity Genetics raises £3m seed round led by Eos Advisory to establish RNA-based gene therapy control systems

Concinnity Genetics develops RNA based control systems that allow gene and cell therapies to be adjusted after dosing, improving safety and flexibility in advanced medical treatments.